Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders - Boffa, MB; Nesheim, ME; Koschinsky, ML (Curr Drug Targets Cardiovasc Haematol Disord, 2001)